AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02643472 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Parent Navigator
Description: Parents will be contacted by the parent navigator within 2 business days after discharge to assess how the family is coping, answer questions, and provide necessary resources. Navigators will be in touch with families monthly and according to the parent's needs. They will assist the parent in making and keeping appointments, answer questions about insurance coverage, medical equipment and supplies, and serve as a liaison between parent and healthcare providers. However, the specific PN intervention for each family will be based on each family's needs and therefore may differ.
Study NCT02643472 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Care Notebook
Description: A care notebook will be provided to all parents at discharge. The notebook was created to provide resources and serve as an organizer for appointments for parents of NICU graduates. It was based on peer to peer feedback from former NICU parents, in addition, to community resources developed by current Parent Navigator Program at Children's National Health System.
Study NCT02643472 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Care Notebook
Description: A care notebook will be provided to all parents at discharge. The notebook was created to provide resources and serve as an organizer for appointments for parents of NICU graduates. It was based on peer to peer feedback from former NICU parents, in addition, to community resources developed by current Parent Navigator Program at Children's National Health System.
Study NCT03448770 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PEG- 17 gm sachet
Description: PEG- 17 gm sachet 3-4 times per day
Study NCT03448770 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Lactulose : 20-30gm
Description: Lactulose : 20-30gm
Study NCT03750786 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Arfolitixorin
Description: Bevacizumab 5 mg/kg intravenous infusion; Oxaliplatin 85 mg/m2 intravenous infusion; 5-FU 400 mg/m2 intravenous bolus; Arfolitixorin 60 mg/m2 intravenous bolus; 5-FU 2400 mg/m2 intravenous infusion; Arfolitixorin 60 mg/m2 intravenous bolus
Study NCT03750786 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Leucovorin
Description: Bevacizumab 5 mg/kg intravenous infusion; Oxaliplatin 85 mg/m2 intravenous infusion; Leucovorin 400 mg/m2 intravenous infusion; 5-FU 400 mg/m2 intravenous infusion; 5-FU 2400 mg/m2 intravenous infusion
Study NCT04198064 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Bag Squeeze
Description: Participants will receive a bag squeeze of irrigation fluid (500 ml/\~2 cups of % 0.9 saline solution) during the insertion of the cystocopy tube during their cystocopy.
Study NCT04198064 — intervention group
Intervention type: PROCEDURE
Group type: OTHER
Intervention: No Bag Squeeze
Description: Participants will receive a standard cystocopy procedure as per standard of care.
Study NCT01120730 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: fluid resuscitation
Description: fluid resuscitation with HES
Study NCT01120730 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Fluid resuscitation
Description: Fluid resuscitation in standardized fashion
Study NCT02928159 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Mecta spectrum 5000Q device
Description: LAP-ST and Right Unilateral (RUL) electrode placement.
Study NCT02905448 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Low fat plant-based nutrition
Description: Conventional low fat plant-based meals free from animal source foods three times daily.~Plant-based meal replacement with Herbalife European Free From Vanilla formula two times daily.~Herbal beverage two times daily. Dietary fiber supplements is taken three times daily (10-36w) and more high fat whole plant-based foods (avocado, tofu, seeds) Conventional food intake is taken ad libitum and no calorie counts or restrictions will be applied.~From 10 to 36 weeks we added vitamin B12 and EPA+DHA fatty acid
Study NCT04374214 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Complete Pulpotomy using Mineral Trioxide Aggregate
Description: Inflammed coronal pulp tissue will be removed till the canal orifices and mineral trioxide aggregate placed over the amputated pulp stump.
Study NCT04374214 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Complete Pulpotomy using Simvastain -alphatricalcium phosphate
Description: Inflammed coronal pulp tissue will be removed till the canal orifices and Simvastatin -alpha tricalcium phosphate placed over the amputated pulp stump.
Study NCT00163280 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ATL-104
Description: Daily does of ATL-104 (50,100 or 150mg) or placebo for 3 days prior to the start of chemotherapy and peripheral blood stem cell transplantation. Following stem cell transplantation patients received 3 further daily doses of ATL-104 (50, 100 or 150mg) or placebo.
Study NCT00163280 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: ATL-104
Description: Daily does of ATL-104 (50,100 or 150mg) or placebo for 3 days prior to the start of chemotherapy and peripheral blood stem cell transplantation. Following stem cell transplantation patients received 3 further daily doses of ATL-104 (50, 100 or 150mg) or placebo.
Study NCT05180643 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Mindfulness-Based Stress Reduction-based program (MBSR).
Description: The MBSR program is built over 8 weeks (1 information session, 8 group sessions from 2h30 to 3h and 1 full day). A trained MBSR instructor will lead group sessions weekly for approximately 150-210 minutes to teach and demonstrate the practices. Practices include walking/standing/supine meditation, body scanning (drawing attention to various areas of the body such as the right foot or left hand), and simple hatha yoga postures. Exercises are the basis of this group learning with practice time and practice exchange time. Participants are asked to commit to daily meditation at home using audioguides for 40 minutes to 1 hour.
Study NCT01862380 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Functional explorations
Description: Functional explorations of cortisol and aldosterone production during stimulation by ITT and sodium depletion respectively
Study NCT00571467 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PRTX-100 (Staphylococcal protein A)
Description: 4 weekly IV (in the vein) doses of 1 of the 3 following PRTX-100 dose levels:~* Cohort 1: 0.075 mcg/kg~* Cohort 2: 0.15 mcg/kg~* Cohort 3: 0.30 mcg/kg
Study NCT00818779 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Aliskiren
Description: 150 - 300 mg once daily for 6 weeks
Study NCT00818779 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Amlodipine
Description: 5-10 mg once daily for 6 weeks
Study NCT02302378 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Lumbar paramedian approach at L3-L4 interspace
Description: Spinal anesthesia will be performed via a lumbar paramedian approach at L3-L4 interspace using 12.5mg 0.5% Bupivacaine (preservative free)
Study NCT02302378 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Taylor's approach (paramedian approach at L5-S1 interspace)
Description: Spinal anesthesia will be performed via Taylor's approach (paramedian approach at L5-61 interspace) using 12.5mg 0.5% Bupivacaine (preservative free)
Study NCT03682302 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Exparel
Description: EXPAREL 4mg/kg (maximum 266 mg)
Study NCT03682302 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: 0.5% Bupivacaine HCl
Description: Bupivacaine HCl 2mg/kg
Study NCT03793036 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: preoperative nutrition
Description: The participants of experimental group received 400 mil of a clear carbohydrate drink (12,5 gr/100 mil carbohydrate, 50 kcal/100ml, pH 5.0) at 10:00 pm the evening before surgery and another 200 mil of the carbohydrate drink on the day of surgery, 2 hours before induction of anesthesia. After surgery the participants fasted until the recovery of function of the bowel.
Study NCT00939159 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: LBH589
Description: 20 mg capsules by mouth 3 times a week for 3 weeks in a 28-day cycle.
Study NCT01393145 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Combination Fluticasone /Formoterol 12/250 μg
Description: Capsules containing Fumarate formoterol 12 µg + fluticasone propionate 250 µg dry powder for inhalation with aerocaps®
Study NCT01393145 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Seretide Diskus (salmeterol/fluticasone) 50/250 μg
Description: Capsules containing salmeterol xinafoate 72.5 µg (equivalent to 50 µg of salmeterol) presented as powder for aspiration, packed in a plastic device in disk format, containing 60 doses
Study NCT02915146 — intervention group
Intervention type: RADIATION
Group type: ACTIVE_COMPARATOR
Intervention: combined ultraviolet phototherapy (NB-UVB + UVA1) vs. NB-UVB monotherapy
Description: NB-UVB combined with UVA1
Study NCT00856440 — intervention group
Intervention type: DRUG
Intervention: Fleets Oral Sodium Phosphate Solution (OSPS)
Description: Osmotic preparation for colonoscopy
Study NCT04619784 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pilates Exercises
Description: Patients will receive 12 sessions of pilates.
Study NCT04619784 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: control
Description: Their routine medical treatments were continued
Study NCT02250339 — intervention group
Intervention type: OTHER
Intervention: LAKU family program
Description: Multi-systemic and multicomponent family-based intervention program
Study NCT02250339 — intervention group
Intervention type: OTHER
Intervention: Etä-LAKU family program
Description: Ecosystem-based intervention for families living in rural parts of Finland
Study NCT02250339 — intervention group
Intervention type: OTHER
Intervention: Family therapy
Description: Treatment as usual (TAU)
Study NCT01898247 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Simulation-based mastery learning
Description: Internal Medicine residents are randomly selected to undergo simulation-based mastery learning.
Study NCT01463787 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: microsurgical varicocelectomy in inguinal approach
Description: In inguinal approach, the incision, which was about 3cm, was made two fingers up the pubic symphysis, from external inguinal rings parallel to the inguinal ligament.
Study NCT01463787 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: microsurgical varicocelectomy in subinguinal approach
Description: In subinguinal approach, the incision was about 3 cm horizontal and 1 cm below the external inguinal ring.
Study NCT02993848 — intervention group
Intervention type: OTHER
Intervention: No intervention
Study NCT00856440 — intervention group
Intervention type: DRUG
Intervention: Colyte
Description: Lavage preparation for colonoscopy
Study NCT00856440 — intervention group
Intervention type: DRUG
Intervention: Dual (OSPS & Colyte)
Description: Combined, two-day preparation utilizing both preparations
Study NCT03540563 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Blood draw
Description: Blood will be drawn to assess ctDNA
Study NCT01098318 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Herbal extract
Description: 340-1,360 mg daily
Study NCT01098318 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Sertraline
Description: 50-200 mg daily
Study NCT01098318 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Lactose monohydrate
Description: 1-4 capsules daily
Study NCT03581760 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Cycling Exercise
Description: Cycling exercise will be performed in the patients once a day.
Study NCT03581760 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Conventional Physiotherapy
Description: Conventional physiotherapy will be performed in the patients twice a day.
Study NCT03581760 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Conventional Physiotherapy
Description: Conventional physiotherapy will be performed in the patients twice a day.
Study NCT01369771 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tafluprost 0.0015%
Description: Eye Drops, Solution. Topical Use. One single-unit dose pipet of 0.3 ml solution including 0.0015 mg/ ml of Tafluprost once daily in the affected eye(s)for 12 months.
Study NCT02421575 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine
Description: Given PO
Study NCT02421575 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Laboratory Biomarker Analysis
Description: Correlative studies
Study NCT00655018 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Vitamin treatment (alpha tocopherol plus ascorbic acid)
Description: alpha tocopherol 600 IU/d plus ascorbic acid 500 mg/d and lifestyle intervention \[hypocaloric Diet(25-30 cal/kg/d) or isocaloric (40-45 cal/kg/d) and physical activity\].
Study NCT00655018 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: placebo and lifestyle intervention \[hypocaloric Diet(25-30 cal/kg/d) or isocaloric (40-45 cal/kg/d) and physical activity\].
Study NCT02712710 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: functional knee brace
Description: The functional knee brace for OA can decrease abnormal varus torque by external force.
Study NCT01632540 — intervention group
Intervention type: DRUG
Intervention: Beclomethasone Dipropionate (BDP) Nasal Aerosol
Description: BDP nasal aerosol 320 mcg/day will be administered to all patients as 2 sprays in each nostril once daily.
Study NCT02546622 — intervention group
Intervention type: BIOLOGICAL
Intervention: Factor VIII Replacement Products for Hemophilia which were FDA approved after January 1, 2013
Description: Prophylaxis for prevention of bleeding, various regimens.
Study NCT02546622 — intervention group
Intervention type: BIOLOGICAL
Intervention: Factor IX Replacement Products for Hemophilia which were FDA approved after January 1, 2013
Description: Prophylaxis for prevention of bleeding, various regimens.
Study NCT01089738 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-03382792 0.5mg
Description: 0.5 mg PF-03382792, qd, for 14 days or placebo
Study NCT01089738 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-03382792 1.5 mg
Description: 1.5 mg PF-03382792, qd, for 14 days or placebo
Study NCT01089738 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-03382792 5 mg
Description: 5 mg PF-03382792, qd, for 14 days or placebo
Study NCT01089738 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PF-03382792 15 mg
Description: 15 mg PF-03382792, qd, for 14 days or placebo
Study NCT01028729 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Endostar
Description: 7.5mg/m2/day, iv, from day 1 to day 14
Study NCT01574196 — intervention group
Intervention type: OTHER
Intervention: Autonomic nervous system activity records
Description: The description of autonomic equilibrium is based on the use of non-invasive tools such as Holter-ECG monitor (24 hours) which is suitable for longitudinal follow up of cohorts of patients. This tool allows the analysis of instantaneous or delayed variability of the heart rate, in the Hertzian frequency domain after extraction and mathematical transformation of a temporal sequence of R-R spaces from the ECG signal.
Study NCT01135303 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: VistaO2 device
Description: Full night VistaO2 device monitoring synchronized with the gold standard polysomnography.
Study NCT04630288 — intervention group
Intervention type: DRUG
Intervention: Clopidogrel
Description: Describe the safety of Ticagrelor vs Clopidogrel use, in patients with ACS in terms of major bleeding between 30 days and one year after the index ACS event. An ITT approach and IPCW method to adjust for change of initial treatment will be used for the analysis.
Study NCT01028729 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gemcitabine-Cisplatin chemotherapy
Description: Gemcitabine 1000 mg/m2, iv, on day 1, 8 Cisplatin 80mg/m2, iv, on day 1, 2, 3
Study NCT03490955 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: salad dressing (canola oil) and black pepper
Description: Subjects will consume a vegetable salad with black pepper and dressing (canola oil) one time in the morning
Study NCT03490955 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: salad dressing (canola oil)
Description: Subjects will consume a vegetable salad with dressing (canola oil) one time in the morning
Study NCT03490955 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: black pepper
Description: Subjects will consume a vegetable salad without dressing (canola oil) but with black pepper one time in the morning
Study NCT04630288 — intervention group
Intervention type: DRUG
Intervention: Ticagrelor
Description: Describe the safety of Ticagrelor vs Clopidogrel use, in patients with ACS in terms of major bleeding between 30 days and one year after the index ACS event. An ITT approach and IPCW method to adjust for change of initial treatment will be used for the analysis.
Study NCT04842370 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PHI-101
Description: PHI-101, oral, once-daily administration, consisting of 28-days per 1 cycle
Study NCT03490955 — intervention group
Intervention type: OTHER
Group type: SHAM_COMPARATOR
Intervention: salad
Description: Subjects will consume a vegetable salad without dressing (canola oil) and without black pepper one time in the morning
Study NCT03490955 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Salad dressing (olive oil) and black pepper
Description: Subjects will consume a vegetable salad with black pepper and dressing (olive oil) one time in the morning
Study NCT03490955 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Salad dressing (corn oil) and black pepper
Description: Subjects will consume a vegetable salad with black pepper and dressing (corn oil) one time in the morning
Study NCT03490955 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Salad dressing (sunflower oil) and black pepper
Description: Subjects will consume a vegetable salad with black pepper and dressing (sunflower oil) one time in the morning
Study NCT03490955 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Salad dressing (flaxseed oil) and black pepper
Description: Subjects will consume a vegetable salad with black pepper and dressing (flaxseed oil) one time in the morning
Study NCT04966286 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: multimedia education
Description: The MLEP intervention was based on a literature review of prior research on the content and format of self care related multimedia education programmes
Study NCT04966286 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: multimedia education
Description: The MLEP intervention was based on a literature review of prior research on the content and format of self care related multimedia education programmes
Study NCT04557553 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Lagenbone
Description: Traditional Chinese medicine herbal formula
Study NCT02541370 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: anti-CD133-CAR vector-transduced T cells
Description: genetically engineered lymphocyte therapy
Study NCT04877353 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: NIV
Description: NIV applied for approximately 30 to 45 min at 2- to 4-h intervals for 48 h following surgery
Study NCT02865239 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Position for the 3.0 Tesla in Magnetic Resonance Imaging
Description: Eligible patients will have a standard MRI in prone position. At the end of this examination, all patients will have an other standard MRI in supine position.~This examination is then extended by 10 minutes without additional injection of contrast medium
Study NCT02865239 — intervention group
Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: Position for the 3.0 Tesla in Magnetic Resonance Imaging
Description: Eligible patients will have a standard MRI in prone position. At the end of this examination, all patients will have an other standard MRI in supine position.~This examination is then extended by 10 minutes without additional injection of contrast medium
Study NCT01796379 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: High Intensity Interval Training
Description: 9 months of high intensity interval based aerobic exercise (3 times/week)
Study NCT01796379 — intervention group
Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Moderate Training
Study NCT02260323 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: patient-tailored anti-arthritis herbs
Description: patient use tailored anti-arthritis herbs
Study NCT02260323 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: patient-tailored DMARDs
Description: patient use tailored disease-modifying antirheumatic drugs
Study NCT03955510 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Right time eating
Description: Right-time eating means breakfast before 8am, lunch before 1 pm and dinner before 6pm. Subjects will be asked to stick to this eating schedule for 1 week. Subjects will randomly be assigned to each eating pattern during the study period. Each subject will be required to do this intervention twice during the study period. One time they will have right time eating with alcohol , the second time the will have this intervention without alcohol.
Study NCT01073644 — intervention group
Intervention type: DRUG
Intervention: Sunitinib malate
Description: sunitinib 50 mg, 4 weeks on, 2 weeks off